PLYMOUTH MEETING, PA — Biotechnology firm INOVIO (NASDAQ: INO) has announced its participation in a series of prominent investor conferences throughout May 2024, signaling a busy month ahead for the company’s top management. Dr. Jacqueline Shea, President & CEO of INOVIO, is slated to represent the company across all events, focusing on a format that encourages direct dialogue and engagement with attendees.
The lineup kicks off with the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 11:30 AM ET, where Dr. Shea will engage in a fireside chat. This session marks the beginning of INOVIO’s active engagement with the investment community during the month. Following closely is the RBC Capital Markets 2024 Global Healthcare Conference, scheduled for Wednesday, May 15, 2024, at 10:00 AM ET, promising another opportunity for in-depth discussion on the company’s direction and strategy.
Additionally, INOVIO will also participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on Monday, May 20, 2024, at 12:30 PM ET. These back-to-back appearances underscore INOVIO’s proactive approach to communication with investors and the broader financial community.
Furthermore, Dr. Shea along with other members of INOVIO’s management team will conduct one-on-one meetings with registered investors, offering a more personalized interaction platform.
For those unable to attend in person, INOVIO is ensuring accessibility by providing webcasts of the fireside chats through the INOVIO Investor Relations Events page. These webcasts, along with their replays, will be accessible for 90 days post-presentation, catering to a wider audience and ensuring that interested parties have ample opportunity to engage with the company’s insights and updates.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.